CMF
PRCT icon

Counterpoint Mutual Funds’s Procept Biorobotics PRCT Stock Holding History

Counterpoint Mutual Funds’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,814
Closed -$388K – 384
2024
Q4 		$388K Buy
+4,814
New +$411K 0.05% 160
2024
Q3 		– Sell
-3,411
Closed -$208K – 359
2024
Q2 		$208K Buy
+3,411
New +$203K 0.05% 187

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Counterpoint Mutual Funds's PRCT Position: Q1 2025 in Review

Counterpoint Mutual Funds sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 4,814 shares — an estimated $388K sold.

Counterpoint Mutual Funds first reported a position in PRCT in Q2 2024 and held it in 2 quarters. The position peaked at $388K in Q4 2024. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

  • Counterpoint Mutual Funds reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 4,814 Procept Biorobotics shares in Q1 2025, an estimated $388K.
  • Counterpoint Mutual Funds first reported a position in Procept Biorobotics in Q2 2024 and held it in 2 quarters.
  • Counterpoint Mutual Funds's Procept Biorobotics position peaked at $388K in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2025, filed 12 Feb 2026.